Alpargatas S.A. (BVMF:ALPA3)

Verve Therapeutics Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,556	4,112	6,937	9,088	19,617	23,136
Market Cap Growth	-4.84%	-40.73%	-23.67%	-53.67%	-15.21%	32.06%
Enterprise Value	5,529	4,256	7,959	9,388	19,304	23,289
Last Close Price	7.40	5.71	10.27	11.72	30.37	37.07
PE Ratio	28.41	38.08	-	74.82	28.45	165.03
PS Ratio	1.30	1.00	1.86	2.17	4.97	7.36
PB Ratio	1.37	1.02	1.86	1.58	5.66	7.67
P/TBV Ratio	1.54	1.15	2.15	1.76	6.78	8.96
P/FCF Ratio	10.59	5.99	175.29	-	45.62	182.48
P/OCF Ratio	7.98	4.87	18.67	-	25.22	74.21
EV/Sales Ratio	1.30	1.04	2.13	2.25	4.89	7.41
EV/EBITDA Ratio	19.22	28.58	-	19.53	28.33	51.96
EV/EBIT Ratio	42.02	193.70	-	23.65	31.37	61.29
EV/FCF Ratio	10.54	6.20	201.12	-	44.89	183.68
Debt / Equity Ratio	0.21	0.40	0.45	0.25	0.08	0.18
Debt / EBITDA Ratio	2.09	8.24	-	2.76	0.40	1.07
Debt / FCF Ratio	2.25	2.35	42.21	-	0.67	4.31
Asset Turnover	0.68	0.62	0.50	0.51	0.62	0.67
Inventory Turnover	2.56	2.74	1.88	1.89	2.31	2.20
Quick Ratio	1.56	2.00	2.19	1.50	0.35	1.47
Current Ratio	2.25	2.56	3.25	2.52	0.75	2.10
Return on Equity (ROE)	6.44%	2.77%	-39.37%	3.98%	20.43%	8.23%
Return on Assets (ROA)	2.27%	0.21%	-3.24%	3.00%	5.99%	5.09%
Return on Capital (ROIC)	2.75%	0.25%	-3.82%	4.54%	10.51%	6.83%
Return on Capital Employed (ROCE)	4.80%	0.40%	-	5.70%	16.50%	10.70%
Earnings Yield	3.52%	2.63%	-26.91%	1.34%	3.52%	0.61%
FCF Yield	9.44%	16.68%	0.57%	-14.74%	2.19%	0.55%
Dividend Yield	1.33%	-	-	-	1.43%	-
Payout Ratio	0.00%	0.02%	-	73.51%	21.55%	21.55%
Buyback Yield / Dilution	-0.78%	-0.27%	0.40%	-17.65%	-0.89%	-0.02%
Total Shareholder Return	0.55%	-0.27%	0.40%	-17.65%	0.54%	-0.02%

Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.